Cardiac Ablation Market OverviewThe cardiac ablation market is set to grow at an impressive CAGR of approximately 13% over the forecast period, driven by a combination of clinical, technological, and ...
PhilStar Global on MSN

Good faith implementation

A lot has been said about the recent decision of the Supreme Court declaring as unconstitutional a provision in the 2024 General Appropriations Act (GAA) which mandated the transfer of P89.9 billion ...
KESTRA MEDICAL TECHNOLOGIES, LTD. (NASDAQ:KMTS) Q2 2026 Earnings Call Transcript December 11, 2025 KESTRA MEDICAL TECHNOLOGIES, LTD. misses on earnings expectations. Reported EPS is $-0.62 EPS, ...
The financing comes as the FDA has lifted a clinical hold on the firm's MyPEAK-1 trial testing TN-201 in MYBPC3-associated hypertrophic cardiomyopathy.
Detailed price information for Milestone Pharmaceuticals Inc (MIST-Q) from The Globe and Mail including charting and trades.
Detailed price information for Cadrenal Therapeutics Inc (CVKD-Q) from The Globe and Mail including charting and trades.